Sanofi and Abu Dhabi Department of Health Collaborate to Accelerate Vaccine Development
CompanyDeals

Sanofi and Abu Dhabi Department of Health Collaborate to Accelerate Vaccine Development

Platinum Life Biotech's Ruibosheng First Prescribed in China for aGVHD Treatment
CompanyDrug

Platinum Life Biotech’s Ruibosheng First Prescribed in China for aGVHD Treatment

MindRank's MDR-001 Phase IIb Study Achieves Clinical Endpoints for Weight Loss
CompanyDrug

MindRank’s MDR-001 Phase IIb Study Achieves Clinical Endpoints for Weight Loss

Eccogene Announces First Patient Dosing in Phase Ib Study of AZD5004/ECC5004 in China
CompanyDrug

Eccogene Announces First Patient Dosing in Phase Ib Study of AZD5004/ECC5004 in China

Simcere Zaiming Initiates US Phase I Study of SIM0500 for Relapsed/Refractory Multiple Myeloma
CompanyDrug

Simcere Zaiming Initiates US Phase I Study of SIM0500 for Relapsed/Refractory Multiple Myeloma

FDA Launches 'Elsa' AI Tool to Enhance Staff Efficiency in Regulatory Processes
DrugMedical Device

FDA Launches ‘Elsa’ AI Tool to Enhance Staff Efficiency in Regulatory Processes

FDA Launches Immediate Review of Clinical Trials Involving Cell Transfer to Hostile Countries
DrugPolicy / Regulatory

FDA Launches Immediate Review of Clinical Trials Involving Cell Transfer to Hostile Countries

Gilead's Yeztugo Approved by FDA as First Six-Monthly Injectable HIV PrEP
CompanyDrug

Gilead’s Yeztugo Approved by FDA as First Six-Monthly Injectable HIV PrEP

Fosun Pharma's Fumaining Launches Clinically for Rare Disease Treatment in China
CompanyDrug

Fosun Pharma’s Fumaining Launches Clinically for Rare Disease Treatment in China

FDA Launches Commissioner’s National Priority Voucher Program for Accelerated Drug Reviews
DrugPolicy / Regulatory

FDA Launches Commissioner’s National Priority Voucher Program for Accelerated Drug Reviews

Hengrui Pharma's Ruitanning Enters Clinical Use for Chemo-Induced Nausea and Vomiting
CompanyDrug

Hengrui Pharma’s Ruitanning Enters Clinical Use for Chemo-Induced Nausea and Vomiting

MSD's Clesrovimab Gears Up for Priority Review in China for RSV Prevention
CompanyDrug

Merck’s Clesrovimab Gears Up for Priority Review in China for RSV Prevention